XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.2
SHARE-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of the components and classification of share-based compensation expense
The following table summarizes the components and classification of the Company’s share-based compensation expenses related to stock options and RSUs for the three and six months ended June 30, 2023 and 2022:
Three Months Ended
June 30,
Six Months Ended
June 30,
(in millions)2023202220232022
Stock options$$$10 $
RSUs 29 23 64 51 
$33 $26 $74 $58 
Research and development expenses$$$$
Selling, general and administrative expenses31 23 69 52 
$33 $26 $74 $58 
Summary of share-based awards
Share-based awards granted for the six months ended June 30, 2023 and 2022 consist of:
20232022
Bausch Health Share-Based Awards
Stock options
Granted999,000 2,570,000 
Weighted-average exercise price$9.25 $23.95 
Weighted-average grant date fair value$4.87 $6.60 
Time-based RSUs
Granted4,667,000 2,680,000 
Weighted-average grant date fair value$9.06 $18.49 
Adjusted Operating Cash Flow performance-based RSUs
Granted647,000 — 
Weighted-average grant date fair value$10.57 $— 
ROTC performance-based RSUs
Granted— 369,000 
Weighted-average grant date fair value$— $9.40 
Bausch+ Lomb Share-Based Awards
Stock options
Granted3,130,000 6,455,000 
Weighted-average exercise price$18.16 $18.00 
Weighted-average grant date fair value$5.40 $4.55 
RSUs
Granted2,888,000 3,207,000 
Weighted-average grant date fair value$17.97 $17.92 
TSR performance-based RSUs
Granted1,175,000 — 
Weighted-average grant date fair value$27.65 $— 
Organic Revenue Growth performance-based RSUs
Granted142,000 — 
Weighted-average grant date fair value$17.96 $—